First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry
| Autor: | Antoine, Leenhardt, Pascal, Defaye, Elisabeth, Mouton, Marc, Delay, Nicolas, Delarche, Jean-Marc, Dupuis, Olivier, Bizeau, Philippe, Mabo, Saida, Cheggour, Dominique, Babuty, Hassan, Mansour |
|---|---|
| Přispěvatelé: | Service de Cardiologie, AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-PRES Sorbonne Paris Cité-Centre de Référence Maladies Cardiaques Héréditaires, Cardiac Stimulation and Rhythmology, CHU Grenoble, Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], OPERA Registry investigators, Service de cardiologie et maladies vasculaires, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes] |
| Jazyk: | angličtina |
| Rok vydání: | 2012 |
| Předmět: |
Male
Tachycardia MESH: Registries medicine.medical_treatment 030204 cardiovascular system & hematology Ventricular tachycardia Cardiac Resynchronization Therapy 0302 clinical medicine Implantable cardioverter defibrillator Tachycardia Supraventricular Registries 030212 general & internal medicine MESH: Incidence 10. No inequality Inappropriate therapy MESH: Treatment Outcome MESH: Aged MESH: Middle Aged Incidence Incidence (epidemiology) Middle Aged Implantable cardioverter-defibrillator Defibrillators Implantable Prosthesis Failure Ventricular tachyarrhythmia Treatment Outcome Cardiology Female [SDV.IB]Life Sciences [q-bio]/Bioengineering France medicine.symptom Cardiology and Cardiovascular Medicine Algorithms medicine.medical_specialty MESH: Cardiac Resynchronization Therapy Cardiac resynchronization therapy MESH: Algorithms MESH: Defibrillators Implantable 03 medical and health sciences MESH: Tachycardia Supraventricular [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system Physiology (medical) Internal medicine medicine Humans In patient Aged MESH: Humans business.industry Mean age medicine.disease Atrial fibrillation MESH: Male Surgery MESH: France Tachycardia Ventricular MESH: Prosthesis Failure MESH: Tachycardia Ventricular Supraventricular tachycardia Supraventricular tachyarrhythmia business MESH: Female |
| Zdroj: | EP-Europace EP-Europace, Oxford University Press (OUP): Policy B, 2012, 14 (10), pp.1465-74. ⟨10.1093/europace/eus144⟩ |
| ISSN: | 1099-5129 1532-2092 |
| Popis: | International audience; AIMS: Inappropriate therapy delivered by implantable cardioverter defibrillators (ICDs) remains a challenge. The OPERA registry measured the times to, and studied the determinants of, first appropriate (FAT) and inappropriate (FIT) therapies delivered by single-, dual- and triple-chamber [cardiac resynchronization therapy defibrillator (CRT-D)] ICD. METHODS AND RESULTS: We entered 636 patients (mean age = 62.0 ± 13.5 years; 88% men) in the registry, of whom 251 received single-, 238 dual-, and 147 triple-chamber ICD, for primary (30.5%) or secondary (69.5%) indications. We measured times to FAT and FIT as a function of multiple clinical characteristics, examined the effects of various algorithm components on the likelihood of FAT and FIT delivery, and searched for predictors of FAT and FIT. Over 22.8 ± 8.8 months of observation, 184 patients (28.9%) received FAT and 70 (11.0%) received FIT. Ventricular tachycardia (VT) was the trigger of 88% of FAT, and supraventricular tachycardia was the trigger of 91% of FIT. The median times to FIT (90 days; range 49-258) and FAT (171 days; 50-363) were similar. The rate of FAT was higher (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|